I. N. Sychev

MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring

Eric Rytkin, Irina V. Bure, Anna G. Saribekian et al. · Drug Metabolism and Personalized Therapy · 2021 · 19 citations

Medicine, Cardiology, Pharmacology +17

Antimicrobial Prescribing Patterns in Patients with COVID-19 in Russian Multi-Field Hospitals in 2021: Results of the Global-PPS Project

Svetlana Rachina, Yuliya Belkova, Roman S. Kozlov et al. · Tropical Medicine and Infectious Disease · 2022 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice

Dmitry Alekseevitch Sychev, O. V. Reshetko, I. N. Sychev et al. · Pharmacogenetics and Genomics · 2022 · 13 citations

Medicine, Cardiology, Pharmacology +16

Diagnosis and antimicrobial therapy of infections caused by polyresistant microorganisms (updated 2024)

Beloborodov Vb, Oleg V. Goloshchapov, V. G. Gusarov et al. · Messenger of Anesthesiology and Resuscitation · 2025 · 11 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +13